Online citations, reference lists, and bibliographies.
← Back to Search

Papillary Thyroid Cancer With Pulmonary Metastases In Children: Long-term Prognosis.

J. Brink, J. V. van Heerden, B. Mciver, D. Salomão, D. Farley, C. Grant, G. Thompson, D. Zimmerman, I. Hay
Published 2000 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
BACKGROUND Papillary thyroid cancer (PTC) in young patients may rarely be encountered with pulmonary metastases. Previous studies have suggested that, in the pediatric population, this may not portend a lethal outcome. Our present study, children with pulmonary metastases, was designed to clarify this issue. METHODS Fourteen children and young adolescents (mean age, 13.5 years; range, 9.8-17 years) with PTC and pulmonary metastases were treated at our institution between 1937 and 1998. Surgical treatment consisted of total thyroidectomy (n = 10 patients), subtotal thyroidectomy (n = 3 patients), and a biopsy only procedure (n = 1 patient). All patients who underwent thyroidectomy also underwent a variety of cervical lymph node dissections, and all patients proved to have regional nodal disease. After the operation, 12 patients were treated with ablative doses of (131)I, 1 patient was treated with external beam irradiation, and all patients were placed on suppressive thyroid hormone therapy. The mean length of follow-up was 19.3 years (range, 1-45 years). RESULTS Regional recurrent disease developed in 2 patients (15%). No patient experienced the development of worsening pulmonary disease or extra-pulmonary metastases. All patients with recurrent disease underwent selective nodal resections. No patient died of metastatic PTC. Seven patients (50%) remain completely free of disease and are probably cured; 7 patients (50%) are asymptomatic with residual pulmonary disease. CONCLUSIONS A stepwise treatment approach allows long-term survival and frequent cure for young patients with PTC and concomitant pulmonary metastases.
This paper references
10.1210/JCEM-16-11-1456
COMPLICATIONS OF THYROID SURGERY
O. Beahrs (1956)
Thyroid carcinoma in childhood.
L. Pfister-Goedeke (1983)
10.1016/S0025-6196(12)62641-X
Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome.
W. Mcconahey (1986)
10.5555/URI:PII:0039606087903400
Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system.
I. Hay (1987)
Early postoperative morbidity after surgical treatment of thyroid carcinoma.
J. V. van Heerden (1987)
Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades.
D. Zimmerman (1988)
10.1001/ARCHSURG.1989.01410120020005
Current results of treatment for distant metastatic well-differentiated thyroid carcinoma.
W. Wood (1989)
10.1016/S0889-8529(18)30310-4
Papillary Thyroid Carcinoma
I. Hay (1990)
10.5555/URI:PII:0039606093903214
Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.
I. Hay (1993)
10.1002/1097-0142(19930215)71:4<1348::AID-CNCR2820710429>3.0.CO;2-3
Pulmonary metastases in children and young adults with differentiated thyroid cancer
R. Vassilopoulou-sellin (1993)
10.1002/MPO.2950240104
Primary thyroid carcinoma in children: a retrospective study of 20 patients.
M. Massimino (1995)
10.1210/JCEM.80.7.7608252
Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades.
S. Dinneen (1995)
10.1002/(SICI)1097-0142(19961115)78:10<2184::AID-CNCR21>3.0.CO;2-U
131‐I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma
J. Sisson (1996)
10.1016/S1055-3207(18)30404-6
Thyroid cancer nodal metastases: biologic significance and therapeutic considerations.
S. Grebe (1996)
10.1002/(SICI)1096-911X(199706)28:6<433::AID-MPO8>3.0.CO;2-H
Papillary thyroid carcinoma: demographics, treatment, and outcome in eleven pediatric patients treated at a single institution.
M. U. Kuefer (1997)
10.1016/S1055-3207(18)30239-4
Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer.
E. Paloyan (1998)
Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.
A. M. Samuel (1998)



This paper is referenced by
10.1016/j.soc.2020.11.013
Management of Differentiated Thyroid Carcinoma in Pediatric Patients.
E. Christison-Lagay (2021)
10.21608/MJCU.2021.167848
Incidence of Recurrent Differentiated Thyroid Carcinoma in Paediatrics and Adolescents after Thyroid Surgery: A Meta-Analysis Study of Last 20 Years
M. B. A. M. AYMAN A. ALBAGHDADY, M.D. (2021)
10.1016/j.jpedsurg.2020.05.003
Pediatric differentiated thyroid carcinoma: An update from the APSA Cancer Committee.
E. Christison-Lagay (2020)
10.1089/thy.2019.0231
Risk stratification of pediatric patients with differentiated thyroid cancer: Is total thyroidectomy necessary for patients at any risk? .
K. Sugino (2020)
10.1007/s00247-020-04804-z
Utility of sonography for identifying metastatic cervical adenopathy in children with differentiated thyroid carcinoma at presentation
M. Navallas (2020)
10.1007/s12020-020-02378-2
Long-term outcome of differentiated thyroid cancer in children and young adults: risk stratification by ATA criteria and assessment of pre-ablation stimulated thyroglobulin as predictors of disease persistence
O. Karapanou (2020)
10.1177/0009922820941207
Pediatric Thyroid Cancer: A Rare Case Report With Miliary Pulmonary Metastases From Well-Differentiated Thyroid Carcinoma
D. Ngo (2020)
10.1016/j.epsc.2020.101542
Miliary pulmonary metastases from well-differentiated pediatric thyroid carcinoma
D. Ngo (2020)
10.3892/OL.2019.10180
Treatment outcomes of differentiated thyroid cancer with distant metastasis improve by tyrosine kinase inhibitors.
H. Iwasaki (2019)
10.1177/1093526619866584
Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features in Children: An Institutional Experience and Literature Review
Huiying Wang (2019)
10.1016/j.asjsur.2017.10.006
Pediatric differentiated thyroid carcinoma: The clinicopathological features and the coexistence of Hashimoto's thyroiditis.
Peiyou Ren (2019)
10.1002/cncy.22104
Incidence and malignancy rates of indeterminate pediatric thyroid nodules
H. Wang (2019)
10.1007/978-3-319-78476-2_66
A Child with Papillary Thyroid Carcinoma: Role of Radioactive Iodine Therapy in Pediatric Patients
Ç. Soydal (2019)
10.1007/978-3-030-03777-2_14
Radioisotope Therapies: Iodine-131, I-131-MIBG, and Beyond
Neha S Kwatra (2019)
10.1097/MNM.0000000000000922
Usefulness of iodine-123 whole-body scan in planning iodine-131 treatment of the differentiated thyroid carcinoma in children and adolescence
M. F. Villani (2018)
10.1007/978-3-319-73782-9
Pediatric Endocrinology
S. Radovick (2018)
10.1515/jpem-2018-0233
Treatment outcomes in pediatric differentiated thyroid carcinoma
N. Bhavani (2018)
10.1007/s00268-018-4487-z
Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors
C. Spinelli (2018)
10.22328/2079-5343-2018-9-2-87-95
LONG-TERM FOLLOW-UP STUDY OF JUVENILE DIFFERENTIATED THYROID CARCINOMA TREATED BY RADIOACTIVE IODINE
Jasna Mihailović (2018)
10.26355/eurrev_201811_16401
Relationship between Hashimoto's thyroiditis and papillary thyroid carcinoma in children and adolescents.
R. Zeng (2018)
10.1007/978-3-319-43618-0_13
The Pediatric Thyroid Nodule and Papillary Thyroid Cancer Management
S. Rivkees (2017)
10.1007/s12020-017-1381-7
Validation of dynamic risk stratification in pediatric differentiated thyroid cancer
S. Sohn (2017)
10.1053/j.semnuclmed.2015.10.006
Management of Differentiated Thyroid Cancer in Children: Focus on the American Thyroid Association Pediatric Guidelines.
M. Parisi (2016)
10.1007/978-1-4939-3314-3_51
Papillary Cancer: Special Aspects in Children
A. Bauer (2016)
10.4158/EP161360.OR
PRE-ABLATION THYROGLOBULIN AND THYROGLOBULIN TO THYROID-STIMULATING HORMONE RATIO MAY BE ASSOCIATED WITH PULMONARY METASTASES IN CHILDREN WITH DIFFERENTIATED THYROID CANCER.
M. Livhits (2016)
10.1016/j.ecl.2016.02.002
Thyroid Cancer in Pediatrics.
J. Machac (2016)
10.1089/THY.2016.0302
Prognostic Factors for Early and Long-Term Remission in Pediatric Differentiated Thyroid Carcinoma: The Role of Sex, Age, Clinical Presentation, and the Newly Proposed American Thyroid Association Risk Stratification System.
B. Pires (2016)
10.17925/USE.2016.12.01.39
How can we apply the new american thyroid association treatment guidelines for children and adolescents with thyroid cancer to improve patient management? Novel insights into clinical experience
A. Bauer (2016)
10.1007/978-1-4939-3314-3_42
Radionuclide Imaging and Treatment of Children with Thyroid Cancer
S. Waguespack (2016)
10.1007/s00268-015-3042-4
Papillary Thyroid Carcinoma in Children and Adolescents: Long-Term Follow-Up and Clinical Characteristics
K. Sugino (2015)
10.1507/endocrj.EJ15-0451
Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
M. Kammori (2015)
10.1515/jpem-2014-0247
Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases
C. Bal (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar